O’Melveny advised Acotec Scientific Holdings on the deal. Acotec Scientific Holdings, executed a voluntary partial offering for a majority stake of up to 65% by US-listed Boston...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and O’Melveny advised Belite Bio on the deal. Belite Bio, Inc., a clinical-stage biopharmaceutical drug development company, announced the pricing of...
You must be a Standard 1 Year member to access this content.
O’Melveny & Myers and Maples and Calder advised Brii Biosciences Limited on the deal. Herbert Smith Freehills has advised Morgan Stanley and UBS. Brii Biosciences Limited...
You must be a Standard 1 Year member to access this content.
O’Melveny & Myers LLP advised BNP Paribas, China Construction Bank International, Industrial and Commercial Bank of China International and other underwriters on the deal. Conyers provided...
You must be a Standard 1 Year member to access this content.
